BioXcel Therapeutics, Inc. (BTAI)
1.51
-0.09
(-5.62%)
USD |
NASDAQ |
Mar 20, 16:00
1.53
+0.02
(+1.32%)
After-Hours: 20:00
BioXcel Therapeutics Total Liabilities (Quarterly) : 133.71M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 169.14M |
| Puma Biotechnology, Inc. | 87.33M |
| Quince Therapeutics, Inc. | 108.84M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.79M |
| Shareholders Equity (Quarterly) | -88.92M |
| Debt to Equity Ratio | -1.229 |
| Current Ratio | 1.175 |
| Net Debt Paydown Yield | -2.21% |